Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: Pooled analysis from MagnetisMM Studies Meeting Abstract
| Authors: | Nooka, A. K.; Lesokhin, A. M.; Mohty, M.; Niesvizky, R.; Maisel, C.; Arnulf, B.; Larson, S. M.; Varshavsky-Yanovsky, A. N.; Leleu, X.; Karlin, L.; Vesole, D. H.; Bahlis, N. J.; de Larrea, C. F.; Raje, N.; Leip, E.; Conte, U.; Phd, M. E.; Viqueira, A.; Manier, S. |
| Abstract Title: | Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: Pooled analysis from MagnetisMM Studies |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | clinical trial; mm; bispecific; b-cell maturation antigen |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S496 |
| End Page: | S497 |
| Language: | English |
| ACCESSION: | WOS:001062479600578 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01447-7 |
| Notes: | Meeting Abstract: MM-374 -- Source: Wos |
